questionsmedicales.fr
Cellules
Neurones
Neurofibres
Neurofibres cholinergiques
Neurofibres parasympathiques postganglionnaires
Neurofibres parasympathiques postganglionnaires : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Dysfonction parasympathique
Tests neurologiques
Électromyographie
Imagerie par résonance magnétique
Sécheresse buccale
Troubles de la digestion
Tests sanguins
Inflammation
Fonction parasympathique
Réponse pupillaire
Symptômes
5
Sécheresse buccale
Constipation
Dysautonomie
Palpitations
Troubles de la sudation
Dysfonction parasympathique
Atteinte nerveuse
Engourdissements
Troubles de la miction
Dysfonction parasympathique
Prévention
5
Prévention
Gestion du stress
Exercice régulier
Système nerveux
Alimentation saine
Santé nerveuse
Contrôle du stress
Symptômes
Bilans de santé
Détection précoce
Traitements
5
Médicaments
Thérapie physique
Médicaments anticholinergiques
Dysfonction
Thérapie comportementale
Qualité de vie
Interventions chirurgicales
Dysfonction
Changements de mode de vie
Alimentation équilibrée
Complications
5
Complications
Troubles digestifs
Troubles de la vision
Atteinte nerveuse
Problèmes de miction
Traitement
Infections urinaires
Dysfonction
Circulation sanguine
Dysfonction nerveuse
Facteurs de risque
5
Stress chronique
Système nerveux
Maladies auto-immunes
Neurofibres
Hérédité
Troubles nerveux
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Neurofibres parasympathiques postganglionnaires : Questions médicales les plus fréquentes",
"headline": "Neurofibres parasympathiques postganglionnaires : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Neurofibres parasympathiques postganglionnaires : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-08",
"dateModified": "2025-03-03",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Neurofibres parasympathiques postganglionnaires"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Neurofibres cholinergiques",
"url": "https://questionsmedicales.fr/mesh/D002799",
"about": {
"@type": "MedicalCondition",
"name": "Neurofibres cholinergiques",
"code": {
"@type": "MedicalCode",
"code": "D002799",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A11.671.501.234"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Neurofibres parasympathiques postganglionnaires",
"alternateName": "Parasympathetic Fibers, Postganglionic",
"code": {
"@type": "MedicalCode",
"code": "D017777",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Rachel M Fenning",
"url": "https://questionsmedicales.fr/author/Rachel%20M%20Fenning",
"affiliation": {
"@type": "Organization",
"name": "Department of Child and Adolescent Studies, Center for Autism, California State University, Fullerton, California, USA."
}
},
{
"@type": "Person",
"name": "Stephen A Erath",
"url": "https://questionsmedicales.fr/author/Stephen%20A%20Erath",
"affiliation": {
"@type": "Organization",
"name": "College of Human Sciences, Auburn University, Auburn, Alabama, USA."
}
},
{
"@type": "Person",
"name": "Jason K Baker",
"url": "https://questionsmedicales.fr/author/Jason%20K%20Baker",
"affiliation": {
"@type": "Organization",
"name": "Department of Child and Adolescent Studies, Center for Autism, California State University, Fullerton, California, USA."
}
},
{
"@type": "Person",
"name": "Frances Rucker",
"url": "https://questionsmedicales.fr/author/Frances%20Rucker",
"affiliation": {
"@type": "Organization",
"name": "New England College of Optometry, 424 Beacon St, Boston, MA, 02115, USA. Electronic address: ruckerf@neco.edu."
}
},
{
"@type": "Person",
"name": "Chris Taylor",
"url": "https://questionsmedicales.fr/author/Chris%20Taylor",
"affiliation": {
"@type": "Organization",
"name": "New England College of Optometry, 424 Beacon St, Boston, MA, 02115, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Lipoplasty in the Overweight Patient.",
"datePublished": "2023-08-08",
"url": "https://questionsmedicales.fr/article/37945074",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.cps.2023.06.010"
}
},
{
"@type": "ScholarlyArticle",
"name": "Boys with overweight status lagged behind girls with overweight status in reading: evidence from mendelian randomization.",
"datePublished": "2023-05-06",
"url": "https://questionsmedicales.fr/article/37156340",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jclinepi.2023.05.001"
}
},
{
"@type": "ScholarlyArticle",
"name": "Overweight grandsons and grandfathers' starvation exposure.",
"datePublished": "2023-07-15",
"url": "https://questionsmedicales.fr/article/37541079",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jhealeco.2023.102796"
}
},
{
"@type": "ScholarlyArticle",
"name": "Homocysteine concentrations in overweight children and adolescents.",
"datePublished": "2023-01-30",
"url": "https://questionsmedicales.fr/article/36722654",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1590/1806-9282.20220991"
}
},
{
"@type": "ScholarlyArticle",
"name": "Cancers attributable to overweight and obesity in Italy.",
"datePublished": "2023-10-11",
"url": "https://questionsmedicales.fr/article/37832242",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.canep.2023.102468"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Cellules",
"item": "https://questionsmedicales.fr/mesh/D002477"
},
{
"@type": "ListItem",
"position": 3,
"name": "Neurones",
"item": "https://questionsmedicales.fr/mesh/D009474"
},
{
"@type": "ListItem",
"position": 4,
"name": "Neurofibres",
"item": "https://questionsmedicales.fr/mesh/D009412"
},
{
"@type": "ListItem",
"position": 5,
"name": "Neurofibres cholinergiques",
"item": "https://questionsmedicales.fr/mesh/D002799"
},
{
"@type": "ListItem",
"position": 6,
"name": "Neurofibres parasympathiques postganglionnaires",
"item": "https://questionsmedicales.fr/mesh/D017777"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Neurofibres parasympathiques postganglionnaires - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Neurofibres parasympathiques postganglionnaires",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-13",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Neurofibres parasympathiques postganglionnaires",
"description": "Comment diagnostiquer une dysfonction parasympathique ?\nQuels examens sont utilisés pour évaluer les neurofibres ?\nQuels symptômes nécessitent un diagnostic ?\nLes tests sanguins sont-ils utiles pour le diagnostic ?\nComment évaluer la fonction parasympathique ?",
"url": "https://questionsmedicales.fr/mesh/D017777?mesh_terms=Overweight#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Neurofibres parasympathiques postganglionnaires",
"description": "Quels sont les symptômes d'une atteinte parasympathique ?\nComment se manifeste une dysautonomie ?\nLes troubles de la sudation sont-ils liés ?\nQuels signes indiquent une atteinte nerveuse ?\nLes troubles de la miction sont-ils fréquents ?",
"url": "https://questionsmedicales.fr/mesh/D017777?mesh_terms=Overweight#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Neurofibres parasympathiques postganglionnaires",
"description": "Peut-on prévenir les troubles parasympathiques ?\nL'exercice régulier aide-t-il à prévenir ?\nUne alimentation saine est-elle bénéfique ?\nLe contrôle du stress est-il important ?\nLes bilans de santé réguliers sont-ils recommandés ?",
"url": "https://questionsmedicales.fr/mesh/D017777?mesh_terms=Overweight#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Neurofibres parasympathiques postganglionnaires",
"description": "Quels traitements sont disponibles pour la dysfonction ?\nLes médicaments anticholinergiques sont-ils utilisés ?\nLa thérapie comportementale est-elle efficace ?\nDes interventions chirurgicales sont-elles possibles ?\nComment les changements de mode de vie aident-ils ?",
"url": "https://questionsmedicales.fr/mesh/D017777?mesh_terms=Overweight#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Neurofibres parasympathiques postganglionnaires",
"description": "Quelles complications peuvent survenir ?\nLes troubles de la vision sont-ils une complication ?\nDes problèmes de miction peuvent-ils s'aggraver ?\nLes infections urinaires sont-elles fréquentes ?\nLes troubles de la circulation sanguine sont-ils possibles ?",
"url": "https://questionsmedicales.fr/mesh/D017777?mesh_terms=Overweight#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Neurofibres parasympathiques postganglionnaires",
"description": "Quels facteurs augmentent le risque de dysfonction ?\nLe stress chronique est-il un facteur de risque ?\nLes maladies auto-immunes sont-elles un risque ?\nL'obésité influence-t-elle le risque ?\nL'hérédité joue-t-elle un rôle ?",
"url": "https://questionsmedicales.fr/mesh/D017777?mesh_terms=Overweight#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une dysfonction parasympathique ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un diagnostic peut inclure des tests neurologiques et des examens d'imagerie."
}
},
{
"@type": "Question",
"name": "Quels examens sont utilisés pour évaluer les neurofibres ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'électromyographie et l'imagerie par résonance magnétique sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Quels symptômes nécessitent un diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme la sécheresse buccale ou des troubles de la digestion peuvent alerter."
}
},
{
"@type": "Question",
"name": "Les tests sanguins sont-ils utiles pour le diagnostic ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent aider à évaluer des marqueurs d'inflammation ou d'autres anomalies."
}
},
{
"@type": "Question",
"name": "Comment évaluer la fonction parasympathique ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de réponse pupillaire et de fréquence cardiaque peuvent être effectués."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une atteinte parasympathique ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent la sécheresse buccale, la constipation et des troubles de la vision."
}
},
{
"@type": "Question",
"name": "Comment se manifeste une dysautonomie ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut se manifester par des vertiges, des palpitations et des troubles digestifs."
}
},
{
"@type": "Question",
"name": "Les troubles de la sudation sont-ils liés ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une dysfonction parasympathique peut entraîner des anomalies de la sudation."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une atteinte nerveuse ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes comme des engourdissements ou des douleurs peuvent indiquer une atteinte."
}
},
{
"@type": "Question",
"name": "Les troubles de la miction sont-ils fréquents ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des problèmes de miction peuvent survenir en raison d'une dysfonction parasympathique."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les troubles parasympathiques ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines mesures préventives incluent un mode de vie sain et la gestion du stress."
}
},
{
"@type": "Question",
"name": "L'exercice régulier aide-t-il à prévenir ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier peut renforcer le système nerveux et prévenir des troubles."
}
},
{
"@type": "Question",
"name": "Une alimentation saine est-elle bénéfique ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation riche en nutriments peut soutenir la santé nerveuse."
}
},
{
"@type": "Question",
"name": "Le contrôle du stress est-il important ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress peut aggraver les symptômes, donc le contrôle est essentiel."
}
},
{
"@type": "Question",
"name": "Les bilans de santé réguliers sont-ils recommandés ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des bilans réguliers peuvent aider à détecter précocement des problèmes."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour la dysfonction ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des médicaments, la thérapie physique et des changements de mode de vie."
}
},
{
"@type": "Question",
"name": "Les médicaments anticholinergiques sont-ils utilisés ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent être prescrits pour traiter certains symptômes de dysfonction."
}
},
{
"@type": "Question",
"name": "La thérapie comportementale est-elle efficace ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut aider à gérer les symptômes et améliorer la qualité de vie."
}
},
{
"@type": "Question",
"name": "Des interventions chirurgicales sont-elles possibles ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Dans certains cas, des interventions chirurgicales peuvent être envisagées."
}
},
{
"@type": "Question",
"name": "Comment les changements de mode de vie aident-ils ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée et l'exercice régulier peuvent améliorer les symptômes."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des troubles digestifs sévères et des problèmes cardiaques."
}
},
{
"@type": "Question",
"name": "Les troubles de la vision sont-ils une complication ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles de la vision peuvent survenir en raison d'une atteinte nerveuse."
}
},
{
"@type": "Question",
"name": "Des problèmes de miction peuvent-ils s'aggraver ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, sans traitement, les problèmes de miction peuvent devenir plus graves."
}
},
{
"@type": "Question",
"name": "Les infections urinaires sont-elles fréquentes ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent survenir en raison de troubles de la miction liés à la dysfonction."
}
},
{
"@type": "Question",
"name": "Les troubles de la circulation sanguine sont-ils possibles ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles de la circulation peuvent survenir en raison d'une dysfonction nerveuse."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque de dysfonction ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des facteurs comme le diabète, l'hypertension et l'âge avancé augmentent le risque."
}
},
{
"@type": "Question",
"name": "Le stress chronique est-il un facteur de risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut contribuer à la dysfonction du système nerveux."
}
},
{
"@type": "Question",
"name": "Les maladies auto-immunes sont-elles un risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines maladies auto-immunes peuvent affecter les neurofibres parasympathiques."
}
},
{
"@type": "Question",
"name": "L'obésité influence-t-elle le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'obésité peut augmenter le risque de troubles nerveux et de dysfonction."
}
},
{
"@type": "Question",
"name": "L'hérédité joue-t-elle un rôle ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de troubles nerveux peuvent augmenter le risque."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 03/03/2025
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Affiliations :
Department of Child and Adolescent Studies, Center for Autism, California State University, Fullerton, California, USA.
Department of Psychological Science and The Claremont Autism Center, Claremont McKenna College, Claremont, California, USA.
Publications dans "Neurofibres parasympathiques postganglionnaires" :
3 publications dans cette catégorie
Affiliations :
College of Human Sciences, Auburn University, Auburn, Alabama, USA.
Publications dans "Neurofibres parasympathiques postganglionnaires" :
3 publications dans cette catégorie
Affiliations :
Department of Child and Adolescent Studies, Center for Autism, California State University, Fullerton, California, USA.
Publications dans "Neurofibres parasympathiques postganglionnaires" :
2 publications dans cette catégorie
Affiliations :
New England College of Optometry, 424 Beacon St, Boston, MA, 02115, USA. Electronic address: ruckerf@neco.edu.
Publications dans "Neurofibres parasympathiques postganglionnaires" :
2 publications dans cette catégorie
Affiliations :
New England College of Optometry, 424 Beacon St, Boston, MA, 02115, USA.
Publications dans "Neurofibres parasympathiques postganglionnaires" :
2 publications dans cette catégorie
Affiliations :
Center for Anatomy and Cell Biology, Institute of Anatomy and Cell Biology - Salzburg Paracelsus Medical University, Salzburg, Austria.
Publications dans "Neurofibres parasympathiques postganglionnaires" :
2 publications dans cette catégorie
Affiliations :
Center for Anatomy and Cell Biology, Institute of Anatomy and Cell Biology - Salzburg Paracelsus Medical University, Salzburg, Austria.
Publications dans "Neurofibres parasympathiques postganglionnaires" :
2 publications dans cette catégorie
Affiliations :
Department of Physiology, Emory University School of Medicine, Atlanta, GA, USA.
Publications dans "Neurofibres parasympathiques postganglionnaires" :
2 publications dans cette catégorie
Affiliations :
Department of Physiology, Emory University School of Medicine, Atlanta, GA, USA.
Publications dans "Neurofibres parasympathiques postganglionnaires" :
2 publications dans cette catégorie
Affiliations :
Department of Physiology, Emory University School of Medicine, Atlanta, GA, USA.
Publications dans "Neurofibres parasympathiques postganglionnaires" :
2 publications dans cette catégorie
Affiliations :
Department of Physiology, Emory University School of Medicine, Atlanta, GA, USA.
Publications dans "Neurofibres parasympathiques postganglionnaires" :
2 publications dans cette catégorie
Affiliations :
Department of Psychological Science, University of California, Irvine, Irvine, CA, United States.
Publications dans "Neurofibres parasympathiques postganglionnaires" :
2 publications dans cette catégorie
Affiliations :
ULR 2694- METRICS: Evaluation des technologies de santé et des pratiques médicales, University of Lille, 59000, Lille, France.
CHU Lille, Department of Neonatology, Jeanne de Flandre Hospital, 59000, Lille, France.
Publications dans "Neurofibres parasympathiques postganglionnaires" :
2 publications dans cette catégorie
Affiliations :
ULR 2694- METRICS: Evaluation des technologies de santé et des pratiques médicales, University of Lille, 59000, Lille, France.
CHU Lille, CIC-IT 1403, Centre D'Innovation Technologique, 59000, Lille, France.
Publications dans "Neurofibres parasympathiques postganglionnaires" :
2 publications dans cette catégorie
Affiliations :
Faculty of Medicine, Osaka University, Osaka, Japan.
Graduate School of Frontiers Bioscience, Osaka University, Osaka, Japan.
Publications dans "Neurofibres parasympathiques postganglionnaires" :
1 publication dans cette catégorie
Affiliations :
Department of Cell Biology, University of Virginia, Charlottesville, Virginia. Electronic address: kld5u@virginia.edu.
Publications dans "Neurofibres parasympathiques postganglionnaires" :
1 publication dans cette catégorie
Affiliations :
Yaroslavl State Medical University, Ministry of Health of the Russian Federation, Yaroslavl, Russia.
Publications dans "Neurofibres parasympathiques postganglionnaires" :
1 publication dans cette catégorie
Affiliations :
Yaroslavl State Medical University, Ministry of Health of the Russian Federation, Yaroslavl, Russia.
Publications dans "Neurofibres parasympathiques postganglionnaires" :
1 publication dans cette catégorie
Affiliations :
Yaroslavl State Medical University, Ministry of Health of the Russian Federation, Yaroslavl, Russia.
Publications dans "Neurofibres parasympathiques postganglionnaires" :
1 publication dans cette catégorie
Affiliations :
Yaroslavl State Medical University, Ministry of Health of the Russian Federation, Yaroslavl, Russia. mpm@ysmu.ru.
Publications dans "Neurofibres parasympathiques postganglionnaires" :
The practice of large volume liposuction, when executed by board-certified plastic surgeons using a variety of energy-assisted liposuction devices, has been substantiated as a secure procedure, yieldi...
We investigated the relationship between childhood weight status and academic achievement across sexes and different school subjects in Norway....
We used data from the Norwegian Mother, Father and Child Cohort Study (MoBa), which includes genetic data (N = 13,648, 8-year-old children). We employed within-family mendelian randomization, using a ...
Contrary to most previous findings, we observed that overweight status (including obesity) has more detrimental effects on reading achievement in boys than in girls; the test scores of boys with overw...
Previous obesity prevention studies have mainly targeted girls, based on the assumption that the obesity penalty is greater for girls. Our findings highlight that particular attention to boys with ove...
Much of the increase in the prevalence of overweight and obesity has been in developing countries with a history of famines and malnutrition. This paper is the first to examine overweight among adult ...
The aim of this study was to describe homocysteine concentrations in overweight and obese children and adolescents and relate them to blood pressure levels, renal function, and insulin resistance....
This is a cross-sectional and observational study with 64 overweight children and adolescents (mean age: 11.6±3.5 years) in outpatient follow-up. The following parameters were evaluated: body mass ind...
The mean body mass index z-score was 2.9±1.1. The mean homocysteine concentrations were 8.6±2.2 μmol/L (10th and 90th percentiles: 6.6 and 11.2 μmol/L, respectively), with no difference when compared ...
Homocysteine concentrations in overweight children and adolescents (mean 8.6±2.2 μmol/L) were not associated with body mass index z-score, blood pressure, renal function, and insulin resistance....
Overweight and obesity are associated with multiple cancers. We quantified the burden of cancer attributable to overweight and obesity in Italy....
We estimated sex- and cancer site-specific population attributable fractions (PAFs) combining relative risks (from recent meta-analyses) with national obesity prevalence data (from a large sample surv...
3.6% of cancers in men and 4.0% in women in Italy were attributable to overweight and obesity, corresponding, respectively, to over 6900 and 7200 diagnoses in 2020. Attributable deaths were over 3600 ...
The cancer burden associated with overweight and obesity in Italy is considerable, but smaller compared to other high income countries, likely because of the lower prevalence of overweight and obesity...
This study aimed to investigate the association between overweight and obesity in postmenopausal women and different aspects related to health such as quality of life, physical activity, sleep quality...
An observational cross-sectional study was carried out during 2021-2022 in Spain in postmenopausal women. Health-related quality of life was assessed using the 12-item short-form survey (SF-12). The P...
A total of 395 postmenopausal women participated: 64.6% (...
Obesity in postmenopausal women negatively affects perceived quality of life, sleep quality, physical activity, the development of cardiovascular problems and pelvic floor-related problems....
Overweight in youth is influenced by genes and environment. Gene-environment interaction (G×E) has been demonstrated in twin studies and recent developments in genetics allow for studying G×E using in...
Latent class growth models of overweight were fitted using data from the TRacking Adolescents' Individual Lives Survey (n = 2720). A polygenic score for body mass index (BMI) was derived using summary...
A three-class model of developmental pathways of overweight fitted the data best ("non-overweight", "adolescent-onset overweight", and "persistent overweight"). The polygenic score for BMI and socioec...
Higher genetic predisposition increased the risk of developing overweight during adolescence and young adulthood and was associated with an earlier age at onset. We did not find that genetic predispos...
Obesity is a major health problem worldwide as it can lead to high blood pressure, heart disease, stroke, diabetes, and insulin resistance. The prevalence of overweight and obesity is increasing world...
To assess the effects of calcium supplementation on weight loss in individuals living with overweight or obesity....
We searched CENTRAL, MEDLINE, Embase, LILACS (Latin American and Caribbean Health Science Information database), and two clinical trials registries. The date of the last search of all databases (excep...
We included randomised controlled trials evaluating the effect of calcium in participants with overweight or obesity of any age or gender. We excluded studies in participants with absorption problems....
We used standard methodological procedures expected by Cochrane. Our primary outcomes were body weight, health-related quality of life, and adverse events. Our secondary outcomes were anthropometric m...
We found 18 studies that evaluated the effect of calcium compared to placebo or control, with a total of 1873 randomised participants (950 participants in the calcium supplementation groups and 923 in...
Calcium supplementation for eight weeks to 24 months may result in little to no difference in body weight in people with overweight or obesity. The current evidence is of low certainty, due to concern...
To evaluate whether a fish oil and/or probiotics intervention in pregnant women with overweight or obesity would influence the tendency of their 24-month-old children to become overweight and alter th...
Women (n = 439) were double-blindly randomized into 4 intervention groups: fish oil+placebo, probiotics+placebo, probiotics+fish oil, and placebo+placebo (fish oil: 1.9 g docosahexaenoic acid and 0.22...
Probiotics+placebo [weight-for-height% adj. Odds ratio (OR) = 0.36, 95% confidence interval (CI) = 0.14-0.95] and probiotics+fish oil [weight-for-age standard deviation score (SD-score) adj. OR = 0.22...
The administration of probiotics solely and in combination with fish oil during pregnancy to women with overweight or obesity lowered the overweight odds of their 24-month-old children....
People living with HIV have greater diabetes (T2DM) than the general population despite lower prevalence of overweight/obesity. Both insulin resistance (IR), a T2DM precursor, and HIV are independentl...
To study the association between inflammation and IR in non-overweight and overweight people living with HIV....
In a cohort of adult people living with HIV with undetectable viral load in Pune, India, we measured fasting insulin, glucose, and 9 inflammatory markers. IR was defined as HOMA-IR ≥2, and non-overwei...
Of 288 participants, 66% (n = 189) were non-overweight. Among non-overweight, prevalence of IR was 34% (n = 65). Each doubling of MCP-1 and leptin was associated with IR on univariate analysis (preval...
One in 3 non-overweight people living with HIV in India with controlled viremia have IR. Leptin was associated with IR among non-overweight people living with HIV and may provide insight into the path...